Cargando…
A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables
BACKGROUND: Early biomarkers are helpful for predicting clinical endpoints and for evaluating efficacy in clinical trials even if the biomarker cannot replace clinical outcome as a surrogate. The building and evaluation of an association model between biomarkers and clinical outcomes are two equally...
Autores principales: | Jiang, Zhiwei, Song, Yang, Shou, Qiong, Xia, Jielai, Wang, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307375/ https://www.ncbi.nlm.nih.gov/pubmed/25528466 http://dx.doi.org/10.1186/1745-6215-15-500 |
Ejemplares similares
-
Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints
por: van der Ploeg, Tjeerd, et al.
Publicado: (2014) -
Analysis of zero inflated dichotomous variables from a Bayesian perspective: application to occupational health
por: Moriña, David, et al.
Publicado: (2021) -
Correction: Analysis of zero inflated dichotomous variables from a Bayesian perspective: application to occupational health
por: Moriña, David, et al.
Publicado: (2022) -
Leveraging hybrid biomarkers in clinical endpoint prediction
por: Saad, Maliazurina, et al.
Publicado: (2020) -
A simulation study on missing data imputation for dichotomous variables using statistical and machine learning methods
por: Ge, Yingfeng, et al.
Publicado: (2023)